back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-13 09:04 Tx date 2026-03-12 |
$ONCY
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,848
+5,050 vol $0.96 each |
114,050 | |
| Filed 2026-02-13 10:03 Tx date 2026-02-12 |
$ONCY
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,839
+29,500 vol $0.84 each |
109,000 | |
| Filed 2026-02-13 10:01 Tx date 2026-02-11 |
$ONCY
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,681
+5,600 vol $0.84 each |
79,500 | |
| Filed 2025-12-19 18:21 Tx date 2025-12-15 |
$ONCY
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$346,500
+350,000 vol $0.99 each |
5,550,000 | |
| Filed 2025-08-22 18:42 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$486,000
+450,000 vol $1.08 each |
5,200,000 | |
| Filed 2025-08-12 16:09 Tx date 2025-08-12 |
$ONC
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,280
+23,500 vol $0.86 each |
73,900 | |
| Filed 2025-07-17 09:00 Tx date 2025-07-16 |
$ONC
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$60,061
+50,400 vol $1.19 each |
50,400 | |
| Filed 2025-07-16 18:07 Tx date 2025-06-11 |
$ONC
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-13 16:36 Tx date 2025-06-11 |
$ONC
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1 vol |
1 | |
| Filed 2025-06-13 16:33 Tx date 2025-06-11 |
$ONC
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,083,000
+1,900,000 vol $0.57 each |
4,750,000 | |
| Filed 2025-06-13 16:32 Tx date 2025-06-11 |
$ONC
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,624,499
+2,850,000 vol $0.57 each |
2,850,000 | |
| Filed 2025-06-12 17:51 Tx date 2025-06-11 |
$ONC
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-12 17:41 Tx date 2025-06-11 |
$ONC
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|